Alessia Beccacece
Overview
Explore the profile of Alessia Beccacece including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
140
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Muglia L, Beccacece A, Soraci L, Caloiero R, Arturi F, Fabbietti P, et al.
J Nutr Health Aging
. 2025 Feb;
29(5):100507.
PMID: 39951931
Objectives: In this study, we aimed at evaluating the association between anticholinergic drug exposure and prevalence, worsening, and incidence of dysphagia among hospitalized older individuals. Design And Setting: We used...
2.
Fedecostante M, Balietti P, Di Santo S, Zambon A, Marengoni A, Morandi A, et al.
BMC Geriatr
. 2024 Sep;
24(1):767.
PMID: 39289644
Background: Delirium is strongly associated with poor health outcomes, yet it is frequently underdiagnosed. Limited research on delirium has been conducted in Nursing Homes (NHs). Our aim is to assess...
3.
Soraci L, Beccacece A, Princiotto M, Villalta Savedra E, Gambuzza M, Aguennouz M, et al.
Front Immunol
. 2024 Sep;
15:1410090.
PMID: 39229268
Immunosenescence refers to the age-related progressive decline of immune function contributing to the increased susceptibility to infectious diseases in older people. Neurocryptococcosis, an infectious disease of central nervous system (CNS)...
4.
Salvi F, Petrino R, Conroy S, Liperoti R, Paoletti L, Beccacece A, et al.
Intern Emerg Med
. 2024 Jul;
19(7):1977-1986.
PMID: 39083165
Constipation and fecal impaction are common issues with the potential for significant morbidity in older people presenting to the Emergency Department (ED). While many of these patients present with classical...
5.
Giancola M, Fontana A, Panebianco C, Mazzarelli A, Beccacece A, De Marco P, et al.
Microorganisms
. 2024 Jul;
12(7).
PMID: 39065211
Background And Aims: Several studies reported the effect of COVID-19 on inducing gut dysbiosis, which is also correlated with disease severity. This study aims to investigate the effect of a...
6.
Muglia L, Di Dio M, Filicetti E, Greco G, Volpentesta M, Beccacece A, et al.
Front Med (Lausanne)
. 2024 Jul;
11:1397160.
PMID: 39055699
Chronic kidney disease (CKD) in older individuals is a matter of growing concern in the field of public health across the globe. Indeed, prevalence of kidney function impairment increases with...
7.
Vita S, Giombini E, De Marco P, Rueca M, Gruber C, Beccacece A, et al.
Mediterr J Hematol Infect Dis
. 2024 Jun;
16(1):e2024043.
PMID: 38882452
No abstract available.
8.
Tetaj N, De Pascale G, Antonelli M, Vargas J, Savino M, Pugliese F, et al.
J Clin Med
. 2024 Mar;
13(6).
PMID: 38541932
Coronavirus disease 2019 (COVID-19) is a significant and novel cause of acute respiratory distress syndrome (ARDS). During the COVID-19 pandemic, there has been an increase in the incidence of cases...
9.
DAbramo A, Vita S, Beccacece A, Navarra A, Pisapia R, Fusco F, et al.
Front Med (Lausanne)
. 2024 Mar;
11:1344267.
PMID: 38487021
Objectives: The aim of the study was to describe a cohort of B-cell-depleted immunocompromised (IC) patients with prolonged or relapsing COVID-19 treated with monotherapy or combination therapy. Methods: This is...
10.
Tempestilli M, Mondi A, DAvolio A, Forini O, Pinnetti C, Mazzotta V, et al.
Int J Antimicrob Agents
. 2023 Dec;
63(2):107068.
PMID: 38141836
Objective: To investigate the pharmacokinetics (PK) of tecovirimat in subjects with Mpox. Methods: This monocentric, prospective, observational study enrolled subjects with Mpox who received standard treatment with oral tecovirimat. Plasma...